Thrombogenic risk factors for cardiovascular disease in dialysis patients

被引：11

作者：

Culleton, BF ^{[1
]}

Wilson, PWF ^{[1
]}

机构：

[1] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA

来源：

SEMINARS IN DIALYSIS | 1999年 / 12卷 / 02期

关键词：

D O I：

10.1046/j.1525-139X.1999.00002.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：117 / 125

页数：9

共 142 条

[1]

*ADA, 1998, DIABETES CARE, V21, P545

[2] INFLAMMATION AND CORONARY-ARTERY DISEASE [J].

ALEXANDER, RW .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (07) :468-469

[3]

[Anonymous], 1996, GUID CLIN PREV SERV

[4] FIBRINOLYTIC CAPACITY IN HEMODIALYSIS-PATIENTS TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN [J].

AUNSHOLT, NA ;

AHLBOM, G ;

STEFFENSEN, G ;

GLUD, T .

NEPHRON, 1992, 62 (03) :284-288

[5]

Bartens W, 1996, PERITON DIALYSIS INT, V16, P27

[6] Fibrinogen is a predictor of mortality in coronary heart disease patients [J].

Benderly, M ;

Graff, E ;

ReicherReiss, H ;

Behar, S ;

Brunner, D ;

Goldbourt, U .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (03) :351-356

[7] REVERSIBLE ACTIVATION DEFECT OF THE PLATELET GLYCOPROTEIN-IIB-IIIA COMPLEX IN PATIENTS WITH UREMIA [J].

BENIGNI, A ;

BOCCARDO, P ;

GALBUSERA, M ;

MONTEAGUDO, J ;

DEMARCO, L ;

REMUZZI, G ;

RUGGERI, ZM .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (05) :668-676

[8]

BERGSTROM J, 1995, J AM SOC NEPHROL, V6, P573

[9]

BISTRIAN BR, 1992, P SOC EXP BIOL MED, V200, P220

[10]

BLANN A, 1993, BRIT J BIOMED SCI, V50, P125

← 1 2 3 4 5 6 7 8 9 10 →